Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: Gene Voss who wrote (4423)	1/8/1998 6:40:00 PM
From: BigKNY3	Read Replies (1) \| Respond to of 23519

Gene: The most influential investigators usually do work with all the major new products being developed in their area of expertise. Dr. Harin Padma-Nathan has done extensive clinical work for Vivus.http://www.vivus.com/frames/prof/abstract/avanatha.htm I seriously doubt whether investigators will ever agree to print their $ amounts that they receive from outside sources. If you anyone thinks it will be so easy, please include the information from your W-2 and 1099s in your next post. It won't happen and who will monitor its accuracy? Dr. Bruce Psaty, a University of Washington researcher, said in today's WSJ :" In general, people don't change their views because they are getting paid. I think drug companies identify people who have views they want to promote." BigKNY3